255 related articles for article (PubMed ID: 2990652)
1. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
2. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
[TBL] [Abstract][Full Text] [Related]
3. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.
Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP
Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878
[TBL] [Abstract][Full Text] [Related]
4. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.
Pedersen C; Kolby P; Sindrup JH; Arendrup M; Wulf HC; Gaub J; Gerstoft J; Lindhardt BO
Dan Med Bull; 1986 Oct; 33(5):270-2. PubMed ID: 2946558
[TBL] [Abstract][Full Text] [Related]
8. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
9. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M
Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729
[TBL] [Abstract][Full Text] [Related]
10. Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years.
Frazer IH; Mackay IR; Crapper RM; Jones B; Gust ID; Sarngadharan MG; Campbell DC; Ungar B
Q J Med; 1986 Oct; 61(234):921-33. PubMed ID: 3498182
[TBL] [Abstract][Full Text] [Related]
11. Immunological findings associated with HTLV-III antibody positivity.
Antonen J
Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
[TBL] [Abstract][Full Text] [Related]
12. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in homosexual men seronegative for HTLV-III.
Ranki A; Valle SL; Antonen J; Suni J; Jokipii L; Jokipii AM; Saxinger C; Krohn K
Cancer Res; 1985 Sep; 45(9 Suppl):4616s-4618s. PubMed ID: 3160458
[TBL] [Abstract][Full Text] [Related]
14. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
15. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
16. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
18. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of lymphocyte subset analysis in AIDS case finding.
Boyko WJ; Schechter MT; MacLeod A; Douglas B; Maynard M; Sharp R; Wiggs B
CMAJ; 1986 May; 134(9):1013-7. PubMed ID: 2938707
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
